Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | TARO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 42.48 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 42.48 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 24.68 - 45.76 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 42.48 | USD |
Taro Pharmaceutical Industries Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.6B | 37.58M | - | 572.95M | 25.45M | 0.68 | 62.74 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Taro Pharmaceutical Indu... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.14 | 42.49 | 42.13 | 42.30 | 20,785 | 0.34 | 0.81% |
| 1 Month | 42.30 | 42.49 | 41.89 | 42.18 | 25,606 | 0.18 | 0.43% |
| 3 Months | 42.75 | 43.05 | 40.45 | 42.11 | 44,573 | -0.27 | -0.63% |
| 6 Months | 33.96 | 45.76 | 32.67 | 41.12 | 42,389 | 8.52 | 25.09% |
| 1 Year | 24.68 | 45.76 | 24.68 | 39.01 | 45,301 | 17.80 | 72.12% |
| 3 Years | 75.58 | 76.4649 | 22.89 | 42.06 | 28,110 | -33.10 | -43.79% |
| 5 Years | 107.07 | 109.42 | 22.89 | 61.11 | 35,119 | -64.59 | -60.33% |
Taro Pharmaceutical Indu... Description
| Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries. |
